Abstract: This study aims to explore the application of eye tracking technology combined with deep learning in disaster map design to improve the visual cognitive efficiency and practicality of maps.

MONTGOMERY, Ala. (WHNT) — High school students across Alabama can apply to dozens of colleges and universities with no application fees this week. The statewide initiative is part of the College ...

Initial filings for unemployment for the week that ended Feb. 14 decreased by 23,000 from the previous week, to 206,000, according to data released Thursday from the Department of Labor. At the end of ...

ASHEVILLE - After multiple delays before the city of Asheville Planning and Zoning Commission, Costco has withdrawn its application to develop at Enka Commerce Park. The company said development on ...

Micro LED display revenue is projected to grow 100% year-over-year (YoY), increasing from $52.4 million in 2025 to $105.4 million in 2026, according to the Omdia Micro LED Display Market Tracker.

If you’re like me and thought the SeniorRx program was only for those at poverty-level incomes, think again. I was wrong. Help is available for many people in Jackson County whose medications are ...

If you’ve noticed it’s more difficult to focus on objects up close as you age, you’re not alone. Approximately 128 million Americans suffer from a common form of vision loss—and the number is only ...

Most patients do well on topical therapy, but innovation in IOP-lowering drops remains essential. One might ask why topical eye drop medications remain the mainstay of glaucoma therapy in the US and ...

Dry eye disease (DED) is a chronic disorder of the ocular surface (OS) that is influenced by a variety of factors, resulting in ocular discomfort and visual impairment. Studies have also shown that ...

Moderna (MRNA) Tuesday said that the U.S. Food and Drug Administration will not initiate a review of the biologics license application for its investigational influenza vaccine, mRNA-1010, and has ...

FDA rejects Moderna's flu vaccine application over trial design issues Moderna shares drop as much as 12% Moderna CEO criticizes FDA's decision, cites prior agreement FDA suggests resubmission for ...